rs149043082
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_002691.4(POLD1):c.1552C>A(p.Leu518Met) variant causes a missense change. The variant allele was found at a frequency of 0.000013 in 1,613,692 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L518L) has been classified as Likely benign.
Frequency
Consequence
NM_002691.4 missense
Scores
Clinical Significance
Conservation
Publications
- POLD1-related polyposis and colorectal cancer syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- colorectal cancer, susceptibility to, 10Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
- mandibular hypoplasia-deafness-progeroid syndromeInheritance: AD, AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Ambry Genetics, Orphanet, G2P
- Polymerase proofreading-related adenomatous polyposisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- immunodeficiency 120Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
- non-severe combined immunodeficiency due to polymerase delta deficiencyInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| POLD1 | NM_002691.4 | c.1552C>A | p.Leu518Met | missense_variant | Exon 13 of 27 | ENST00000440232.7 | NP_002682.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| POLD1 | ENST00000440232.7 | c.1552C>A | p.Leu518Met | missense_variant | Exon 13 of 27 | 1 | NM_002691.4 | ENSP00000406046.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152198Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 250606 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461494Hom.: 1 Cov.: 34 AF XY: 0.00000963 AC XY: 7AN XY: 727078 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152198Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74336 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Colorectal cancer, susceptibility to, 10 Uncertain:2
This sequence change replaces leucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 518 of the POLD1 protein (p.Leu518Met). This variant is present in population databases (rs149043082, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with POLD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 421052). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt POLD1 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not specified Uncertain:1
The p.Leu518Met variant in POLD1 has not been previously reported in individuals with colorectal cancer, but has been identified in 2/66222 of European chromoso mes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; d bSNP rs149043082). Computational prediction tools and conservation analysis sugg est that the p.Leu518Met variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical s ignificance of the p.Leu518Met variant is uncertain. -
not provided Uncertain:1
Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26344056, 20951805) -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.L518M variant (also known as c.1552C>A), located in coding exon 12 of the POLD1 gene, results from a C to A substitution at nucleotide position 1552. The leucine at codon 518 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at